<DOC>
	<DOC>NCT03043183</DOC>
	<brief_summary>This study is a prospective, single-center, randomized controlled trial. The study protocol was approved by the Ethics Committee at the First Hospital of Jilin University.The perioperation nutritional status will be assessed in gastric cancer patients within ERAS protocols.The ERAS patients were randomly divided into perioperational nutrition support group and conventional pathway group . Inter-group differences were evaluated for nutritional index,clinical recovery index, complications etc.</brief_summary>
	<brief_title>Enhanced Recovery After Surgery(ERAS) for Gastric Cancer and Perioperative Nutritional Status</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Nutrition Disorders</mesh_term>
	<criteria>A preoperative cancer stage of T2, T3, T4, Any N, M0 without digestive obstruction confirmed by whole body CT scan, which could be treated with laparoscopic gastrectomy; age 1875 years; pathologic confirmation of gastric adenocarcinoma by endoscopic biopsy; normal hematological, renal, hepatic, and cardiac parameters,American Society of Anesthesiology (ASA) score &lt; III without severe systemic disease; no history of treatment with neoadjuvant chemotherapy and/or radiotherapy PGSGA score ≥2，＜9 patients requiring conversion to open gastrectomy excessive bleeding (˃ 500 mL);and patients opting out of the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>Enhanced recovery after surgery</keyword>
</DOC>